|
09-2021
|
Biomarkers for Lewy Body Dementia
Biomarkers for Lewy Body Dementia
|
|
12-2019
|
Reducing Disability via a Family-centered Intervention for Acutely-Ill Persons with Dementia
Reducing Disability via a Family-centered Intervention for Acutely-Ill Persons with Dementia
|
|
09-2019
|
LBDA Research Center of Excellence Award
LBDA Research Center of Excellence Award
|
|
06-2019
|
A randomized, double-blind, placebo-controlled, two cohort parallel group study to evaluae the efficacy of CAD106 and CNP520 in participants at risk for the onset of clinical symptoms of Alzheimer’s
A randomized, double-blind, placebo-controlled, two cohort parallel group study to evaluae the efficacy of CAD106 and CNP520 in participants at risk for the onset of clinical symptoms of Alzheimer’s
|
|
06-2019
|
A Study to Model Rates of Change on Neuropsychological Test Measures in Subjects Diagnosed with Behavioral Variant Frontotemporal Dementia and Healthy Subjects
A Study to Model Rates of Change on Neuropsychological Test Measures in Subjects Diagnosed with Behavioral Variant Frontotemporal Dementia and Healthy Subjects
|
|
03-2019
|
FoxBioNet LRRK2-002
FoxBioNet LRRK2-002
|
|
12-2018
|
The Leo and Anne Albert Charitable Trust Support for Dementia Prevention
The Leo and Anne Albert Charitable Trust Support for Dementia Prevention
|
|
09-2018
|
Biomarkers for Lewy Body Dementia
Biomarkers for Lewy Body Dementia
|
|
08-2018
|
DEMENTIA PREVENTION INITIATIVE: A Personalized Approach to Dementia Prevention
DEMENTIA PREVENTION INITIATIVE: A Personalized Approach to Dementia Prevention
|
|
07-2018
|
Mesoscopic Biomarkers of Neurodegeneration with Diffusion MRI
Mesoscopic Biomarkers of Neurodegeneration with Diffusion MRI
|
|
06-2018
|
Biogen 221AD302
Biogen 221AD302
|
|
05-2018
|
Escitalopram for Agitation in Alzheimer’s Disease Research Group (S-CitAD)
Escitalopram for Agitation in Alzheimer’s Disease Research Group (S-CitAD)
|
|
05-2018
|
Multicultural Community Dementia Screening.
Multicultural Community Dementia Screening.
|
|
03-2018
|
A Multi-Site Cluster RCT of the Dementia Symptom Management At Home Program
A Multi-Site Cluster RCT of the Dementia Symptom Management At Home Program
|
|
03-2018
|
RVT-101-2002: A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects with Dementia with Lewy Bodies (DLB)
RVT-101-2002: A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects with Dementia with Lewy Bodies (DLB)
|
|
02-2018
|
A Phase 2b/3, Randomized...Protocol #54861911ALZ2003
A Phase 2b/3, Randomized...Protocol #54861911ALZ2003
|
|
01-2018
|
Caring For You (C4U): A Novel Intervention to Improve Caregiver and Patient Outcomes
Caring For You (C4U): A Novel Intervention to Improve Caregiver and Patient Outcomes
|
|
01-2018
|
RVT-101-2001, A Phase 2b, double-blind, randomized, placebo-controlled study of RVT-101 in subjects with dementia with Lewy bodies (DLB)
RVT-101-2001, A Phase 2b, double-blind, randomized, placebo-controlled study of RVT-101 in subjects with dementia with Lewy bodies (DLB)
|
|
12-2017
|
RVT-101-2003: A Phase 2, double-blind, randomized, placebo-controlled crossover study evaluating the effect of RVT-101 on gait....
RVT-101-2003: A Phase 2, double-blind, randomized, placebo-controlled crossover study evaluating the effect of RVT-101 on gait....
|
|
10-2017
|
RVT-102-2003: An open-label study of nelotanserin in patients with Lewy body dementia who have frequent visual hallucinations or REM sleep behaviors
RVT-102-2003: An open-label study of nelotanserin in patients with Lewy body dementia who have frequent visual hallucinations or REM sleep behaviors
|
|
07-2017
|
Mesoscopic Biomarkers of Neurodegeneration with Diffusion MRI
Mesoscopic Biomarkers of Neurodegeneration with Diffusion MRI
|
|
07-2017
|
RVT-102-2002: A Phase 2, double-blind, randomized, placebo-controlled study of nelotanserin versus placebo in patients with dementia with Lewy bodies (DLB) experiencing REM sleep behaviors (RBD)
RVT-102-2002: A Phase 2, double-blind, randomized, placebo-controlled study of nelotanserin versus placebo in patients with dementia with Lewy bodies (DLB) experiencing REM sleep behaviors (RBD)
|
|
12-2016
|
The Social and Economic Burden of Frontotemporal Degeneration
The Social and Economic Burden of Frontotemporal Degeneration
|
|
07-2016
|
Mesoscopic Biomarkers of Neurodegeneration with Diffusion MRI
Mesoscopic Biomarkers of Neurodegeneration with Diffusion MRI
|
